Weight Loss Drug
- All
- News
- Videos
- Web Stories
-
Opinion | The Rich Get Fit, And Poor Get 'Lectures' - That's India's Ozempic Problem
Ozempic has arrived in India - and so has the moral panic around it.
-
Why Russian Teenagers Are Obsessed With Molecule, A Controversial Weight Loss Pill
Molecule is claimed to be made from "natural ingredients" such as dandelion root and fennel seed, but investigations tell a different story
-
New Study Finds Diabetes, Weight Loss Drugs May Lower Rheumatoid Arthritis Flares
A study presented at ACR Convergence 2025 suggests that GLP 1 receptor agonists reduce flares and systemic inflammation in Rheumatoid Arthritis (RA) patients.
-
Weight-Loss Breakthrough: Drug Cuts Heart Risk Even If You Don't Shed Kilos
A large-scale study shows semaglutide reduces heart risks regardless of weight loss, suggesting the drug benefits cardiovascular health in more ways than previously thought. The findings highlight waist size as a stronger indicator of heart improveme
-
Mounjaro For Weight Loss Becomes Second-Highest Selling Drug In India In 6 Months
Mounjaro recorded Rs 80 crore in sales in September, trailing only GSK's antibiotic Augmentin, which registered Rs 85 crore
-
Ozempic Is Here In India But It's Not A Magic Weight Loss Pill, Says Nutritionist
Ozempic arrives in India, but nutritionist Nmami Agarwal encourages reasonable expectations amid the hype.
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Novo Nordisk's Ozempic Is Launching In India, Country Head Calls It A "Welcome Change"
Danish drugmaker Novo Nordisk's India Head, Vikrant Shrotiya, shares that the pharmaceutical giant is ready to launch Ozempic in India
-
How This Influencer Lost 60 Kg Without Crash Diets And Weight-Loss Drugs
A German influencer went viral after shedding an impressive 60 kg in five years
-
Ram Kapoor Pokes Fun At Ozempic Rumours After Dramatic Weight Loss Transformation
Ram Kapoor takes a dig at trolls who said he lost weight with a weight loss drug
-
Rising Diabetes In US Kids: Can Mounjaro Be The Answer? New Study Says Yes
A new study reveals Mounjaro may help children as young as 10 manage Type 2 diabetes, significantly reducing blood sugar and weight, with Eli Lilly pushing to expand its use beyond adults.
-
Chrissy Teigen Opens Up About Taking Ozempic After Miscarriage But Noticed 'No Instant Results'
Chrissy Teigen revealed that she temporarily lost her hunger after taking Ozempic
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
At Wellness Resorts, Ozempic Becomes Part Of The Treatment Menu
A 2024 KFF survey found that about 1 in 8 US adults have used a GLP-1 drug like Ozempic.
-
Opinion | The Rich Get Fit, And Poor Get 'Lectures' - That's India's Ozempic Problem
Ozempic has arrived in India - and so has the moral panic around it.
-
Why Russian Teenagers Are Obsessed With Molecule, A Controversial Weight Loss Pill
Molecule is claimed to be made from "natural ingredients" such as dandelion root and fennel seed, but investigations tell a different story
-
New Study Finds Diabetes, Weight Loss Drugs May Lower Rheumatoid Arthritis Flares
A study presented at ACR Convergence 2025 suggests that GLP 1 receptor agonists reduce flares and systemic inflammation in Rheumatoid Arthritis (RA) patients.
-
Weight-Loss Breakthrough: Drug Cuts Heart Risk Even If You Don't Shed Kilos
A large-scale study shows semaglutide reduces heart risks regardless of weight loss, suggesting the drug benefits cardiovascular health in more ways than previously thought. The findings highlight waist size as a stronger indicator of heart improveme
-
Mounjaro For Weight Loss Becomes Second-Highest Selling Drug In India In 6 Months
Mounjaro recorded Rs 80 crore in sales in September, trailing only GSK's antibiotic Augmentin, which registered Rs 85 crore
-
Ozempic Is Here In India But It's Not A Magic Weight Loss Pill, Says Nutritionist
Ozempic arrives in India, but nutritionist Nmami Agarwal encourages reasonable expectations amid the hype.
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Novo Nordisk's Ozempic Is Launching In India, Country Head Calls It A "Welcome Change"
Danish drugmaker Novo Nordisk's India Head, Vikrant Shrotiya, shares that the pharmaceutical giant is ready to launch Ozempic in India
-
How This Influencer Lost 60 Kg Without Crash Diets And Weight-Loss Drugs
A German influencer went viral after shedding an impressive 60 kg in five years
-
Ram Kapoor Pokes Fun At Ozempic Rumours After Dramatic Weight Loss Transformation
Ram Kapoor takes a dig at trolls who said he lost weight with a weight loss drug
-
Rising Diabetes In US Kids: Can Mounjaro Be The Answer? New Study Says Yes
A new study reveals Mounjaro may help children as young as 10 manage Type 2 diabetes, significantly reducing blood sugar and weight, with Eli Lilly pushing to expand its use beyond adults.
-
Chrissy Teigen Opens Up About Taking Ozempic After Miscarriage But Noticed 'No Instant Results'
Chrissy Teigen revealed that she temporarily lost her hunger after taking Ozempic
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
At Wellness Resorts, Ozempic Becomes Part Of The Treatment Menu
A 2024 KFF survey found that about 1 in 8 US adults have used a GLP-1 drug like Ozempic.
